Pregnancy with prolonged fetal exposure to an angiotensin-converting enzyme inhibitor

Journal of Perinatology

Volumn 22, Issue 7, 2002, Pages 582-584

  Muller, Peter R ^a   James, Andra ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; AMLODIPINE; AMLODIPINE PLUS BENAZEPRIL; BENAZEPRIL; BENAZEPRIL PLUS HYDROCHLOROTHIAZIDE; CAPTOPRIL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENALAPRIL MALEATE; ENALAPRIL MALEATE PLUS FELODIPINE; ENALAPRIL PLUS HYDROCHLOROTHIAZIDE; ENALAPRILAT; FOSINOPRIL; FUROSEMIDE; GLYCERYL TRINITRATE; HYDROCHLOROTHIAZIDE PLUS LISINOPRIL; HYDROCHLOROTHIAZIDE PLUS QUINAPRIL; LISINOPRIL; MOEXIPRIL; MONOPRIL HCT; PERINDOPRIL; QUINAPRIL; RAMIPRIL; TRANDOLAPRIL; TRANDOLAPRIL PLUS VERAPAMIL; UNIRETIC;

ACCURACY; ADULT; AMNION FLUID; ARTICLE; BLADDER DISEASE; CARDIOMYOPATHY; CASE REPORT; CHILDBIRTH; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG WITHDRAWAL; ENTEROPATHY; FEMALE; FETOTOXICITY; FETUS DEVELOPMENT; FETUS ECHOGRAPHY; FOLLOW UP; GESTATION PERIOD; HUMAN; HYPERTENSION; LONG TERM EXPOSURE; MEDICAL ASSESSMENT; OLIGOHYDRAMNIOS; OUTCOMES RESEARCH; PARITY; PATIENT COUNSELING; PERICARDIAL EFFUSION; PREGNANCY; PRENATAL DRUG EXPOSURE; SKULL DEFECT;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BENZAZEPINES; CASE REPORT; FEMALE; FETAL HEART; HUMAN; HYPERTENSION; INTESTINES; MATERNAL EXPOSURE; OLIGOHYDRAMNIOS; PREGNANCY; PREGNANCY OUTCOME; SKULL; ULTRASONOGRAPHY, PRENATAL;

EID: 0036772268     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7210766     Document Type: Article

References (9)

1. Braunwald E. Heart Disease: A textbook of Cardiovascular Medicine. St Louis, MO: WB Saunders 2001.
2. Barr M. Teratogen update: angiotensin-converting enzyme inhibitors. Teratology 1994;50:399-409.
3. Henshaw SK. Unintended pregnancy in the United States. Fam Plan Perspect 1998;30:24-9, 46.
4. Pryde PG, Sedman AB, Nugent CE, Barr M, Jr. Angiotensin-converting enzyme inhibitor fetopathy. J Am Soc of Nephrol 1993;3:1575-82.
5. Pryde PG, Barr M, Jr. Low-dose, short-acting, angiotensin-converting enzyme inhibitors as rescue therapy in pregnancy. Obstet Gynecol 2001;97: 799-800.
6. Lip GY, Churchill D, Beevers M, Auckett A, Beevers DG. Angiotensin-converting-enzyme inhibitors in early pregnancy. Lancet 1997;350:1446-7.
7. Burrows RF, Burrows EA. Assessing the teratogenic potential of angiotensin-converting enzyme inhibitors in pregnancy. Aust N Z J Obstet Gynaecol 1998; 38:306-11.
8. Chisholm CA, Chescheir NC, Kennedy M. Reversible oligohydramnios in a pregnancy with angiotensin-converting enzyme inhibitor exposure. Am J Perinatol 1997;14:511-3.
9. PDR.NET. Cardiovascular Agents: Angiotensin Converting Enzyme (ACE) Inhibitors. Montvale, New Jersey: Medical Economics Company, Inc 2002 (vol 2002).